Publications by authors named "Ferras Alwan"

Claim this Profile
A
Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.
Mary I Underwood, Ferras Alwan, Mari R Thomas, Marie A Scully, James T B Crawley

J Thromb Haemost· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura.
Ferras Alwan, Chiara Vendramin, Ulrich Budde, Ri Liesner, Alice Taylor

EJHaem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exchange for COVID-19 thrombo-inflammatory disease.
Nishkantha Arulkumaran, Mari Thomas, David Brealey, Ferras Alwan, Deepak Singh

EJHaem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura.
Ferras Alwan, Dina Mahdi, Sarrah Tayabali, Lisa Cipolotti, Grace Lakey

Br J Haematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and treatment of congenital thrombotic thrombocytopenic purpura.
Ferras Alwan, Chiara Vendramin, Ri Liesner, Amanda Clark, William Lester

Blood· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.
Ferras Alwan, Chiara Vendramin, Karen Vanhoorelbeke, Katy Langley, Vickie McDonald

Blood· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.
John-Paul Westwood, Mari Thomas, Ferras Alwan, Vickie McDonald, Sylvia Benjamin

Blood Adv· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.
Chiara Vendramin, Siobhan McGuckin, Ferras Alwan, John-Paul Westwood, Mari Thomas

Transfusion· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
Ferras Alwan, Annie He, Silvia Montoto, Shireen Kassam, Matthew Mee

AIDS· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis